Stride: Platform Headwinds Behind It, Cheap Valuation Points to Patient Long-Term Upside
Stride (LRN) suffered a steep selloff after platform implementation problems last year, but technical issues are largely resolved, enrollment is showing signs of recovery and valuation is attractive. We recommend a long trade at $84.00 with a $110.00 target over 180 trading days and a $72.00 stop loss, sized for a medium-risk allocation.